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Hyperglycemia during acute myocardial infarction (AMI) is associ-ated with a poor prognosis, and blood glucose level is an inde-
pendent predictor of mortality in patients with or without known
diabetes (1). The future glycometabolic profile of patients suffering
AMI without diabetes can be predicted in the hospital phase (2).
There is also a correlation between blood glucose on hospital admis-
sion for AMI and long-term mortality in patients with or without
known diabetes (3,4). Moreover, hyperglycemia in patients with
ST elevation MI was found to be an important predictor of impaired
epicardial flow (5). In acute coronary syndromes, glucose metabolism
is modified, and stress hyperglycemia commonly occurs (6) secondary
to increased catecholamine levels. Due to stress hyperglycemia, a
method looking only at plasma glucose levels at the time of an AMI
cannot be used to predict the prognosis. Thus, glycosylated hemoglo-
bin (HbA1c) values may reveal diabetes in cases of AMI (7). 
Elevated HbA1c is an important determinant of atherosclerosis
beyond the risk associated with established diabetes (8,9). Thallium-201
(Tl-201) scintigraphy has been used to assess prognosis after AMI, and
the extent and severity of perfusion abnormalities were found to be
closely associated with cardiovascular outcome (10). In the present
study, we evaluated the relationship between admission HbA1c levels
and myocardial perfusion abnormalities in patients with AMI. 
METHODS
Study population
Consecutive patients admitted to the cardiology department of the
Siyami Ersek Cardiac and Thoracic Surgery Center (Istanbul, Turkey)
for AMI between 1998 and 2004 were selected (100 patients; 68 men;
mean age 59.5±9.6 years). AMI was defined according to the European
Society of Cardiology and American College of Cardiology criteria
(11): increased creatine kinase predominantly in the myocardial band
fraction and/or increased cardiac troponin I (creatine kinase 400 U/L
or higher, and/or cardiac troponin I 2 μg/L or higher), ischemic symp-
toms (mainly constrictive chest pain, lasting longer than 30 min),
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BACKGROUND: Glycosylated hemoglobin (HbA1c) level on admis-
sion is a prognostic factor for mortality in patients with and without dia-
betes after myocardial infarction. In the present study, the authors
examined the relationship between admission HbA1c level and myocar-
dial perfusion abnormalities in patients with acute myocardial infarction.
METHODS: One hundred consecutive patients with acute myocardial
infarction who were treated with thrombolytic therapy were included in
the present prospective study. Blood glucose and HbA1c levels of all
patients were measured within 3 h of admission. Patients were divided into
three groups according to HbA1c level: 4.5% to 6.4% (n=25), 6.5% to
8.5% (n=28) and higher than 8.5% (n=47). All patients then underwent
exercise thallium-201 imaging and coronary angiography to determine
ischemic scores and the number of diseased coronary arteries four weeks
after admission. 
RESULTS: Seven patients died within the four-week follow-up period.
There was a significant relationship between admission HbA1c level and
mortality (P=0.009). Furthermore, there was a significant relationship
between HbA1c level and total ischemic scores in patients with acute
myocardial infarction (r=0.482; P=0.001). Ischemic scores increased as
HbA1c levels increased in patients with acute myocardial infarction.
CONCLUSIONS: The results demonstrated that admission plasma glu-
cose and HbA1c levels are prognostic factors associated with mortality
after acute myocardial infarction.
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La valeur du taux d’hémoglobine glycosylée à
l’hospitalisation des patients atteints d’un
infarctus aigu du myocarde
HISTORIQUE : Le taux d’hémoglobine glycosylée (HbAlc) au moment
de l’hospitalisation est un facteur pronostique chez les patients diabétiques
ou non diabétiques après un infarctus du myocarde. Dans la présente étude,
les auteurs ont examiné la relation entre le taux de HbAlc à
l’hospitalisation et les anomalies de perfusion myocardique chez les adultes
atteints d’un infarctus aigu du myocarde.
MÉTHODOLOGIE : Cent patients consécutifs atteints d’un infarctus
aigu du myocarde recevant un traitement thrombolytique faisaient partie
de la présente étude prospective. La glycémie et les taux de HbAlc de tous
les patients ont été mesurés dans les trois heures suivant leur
hospitalisation. Les patients ont été divisés en trois groupes, selon leur taux
de HbAlc : de 4,5 % à 6,4 % (n=25), de 6,5 % à 8,5 % (n=28), et plus de
8,5 % (n=47). Tous les patients ont ensuite subi une imagerie d’épreuves
d’effort au thallium 201 et une coronarographie pour déterminer les
indices ischémiques et le nombre d’artères coronaires atteintes quatre
semaines après l’hospitalisation.
RÉSULTATS : Sept patients sont décédés pendant la période de suivi de
quatre semaines. On a constaté un lien significatif entre le taux de HbAlc
à l’hospitalisation et la mortalité (P=0,009). Le lien était également
significatif entre le taux de HbAlc et les indices ischémiques totaux chez
les patients atteints d’un infarctus aigu du myocarde (r=0,482; P=0,001).
L’augmentation des indices ischémiques était proportionnelle aux taux de
HbAlc chez les patients atteints d’un infarctus aigu du myocarde.
CONCLUSIONS : Les résultats démontrent que les taux de glucose
plasmatique et de HbAlc à l’hospitalisation sont des facteurs pronostiques
de la mortalité après un infarctus aigu du myocarde.
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and/or abnormal electrocardiography (ST elevation 1 mm or greater
on at least two derivations). MI was defined as acute if the time
elapsed between the first symptom and admission was 48 h or less.
Only patients who underwent thrombolytic treatment were included
in the study. 
Exclusion criteria
The following patients were excluded: those in whom primary angio-
plasty was the choice of treatment, those with subacute or chronic MI
(longer than 48 h between first symptom and admission), those with
renal failure and those using antidiabetic medications. 
Study protocol
Blood glucose and HbA1c levels of all patients were measured within
3 h of admission, regardless of whether they had been fasting. Blood
glucose and HbA1c levels were analyzed by the AEROSET system and
the ARCHITECT c8000 system (Abbott Laboratories, USA), respec-
tively. 
The five major risk factors were male sex, obesity, history of hyper-
tension, dyslipidemia and cigarette smoking, which were carefully
evaluated. Smoking status was defined as a patient never having
smoked or currently smoking. Dyslipidemia was defined as a fasting
concentration of serum total cholesterol higher than 5.2 mmol/L. The
fasting lipid profile was determined on the morning following admis-
sion and included total cholesterol, high-density liporotein choles-
terol and triglycerides. Lipoprotein analysis was determined by
automated enzymatic methods. 
Patients were divided into three groups according to the level of
HbA1c: 25 patients with HbA1c levels of 4.5% to 6.4% (group 1),
28 patients with HbA1c levels of 6.5% to 8.5% (group 2) and
47 patients with HbA1c levels higher than 8.5% (group 3).
Patients in group 1 were accepted as nondiabetic, patients in
group 2 as possibly diabetic and patients in group 3 as diabetic, regard-
less of whether it was known previously (12).
None of the patients received glucose, insulin or potassium
infusion therapy during admission. All patients underwent exercise
TI-201 imaging and coronary angiography within the four-week
follow-up after AMI. The study protocol was approved by the institu-
tional ethics committee and all patients provided written, informed
consent before study entry. 
Single photon emission computed tomography acquisition protocol
All patients were investigated according to a one-day rest/stress proto-
col using TI-201 imaging. An Elscint Apex SPX gamma camera
(Elscint, Israel) equipped with a low-energy, all-purpose collimator
was used. Sixty projections of 20 s each were acquired in step-and-
shoot mode over a 180° arc on 64 × 64 matrix with a zooming factor
of 1.4. Image reconstruction was performed using a Butterworth filter
with a cut-off frequency of 0.35 Nyquist and an order of five for
technetium-99m sestamibi imaging.
Image analysis 
Myocardial perfusion was graded on a five-point scale, with the score
representing the reduction of radioisotope uptake (0 = normal; 1 =
equivocal, 2 = moderate, 3 = severe and 4 = absent) using a 20 seg-
ment model (10). Total perfusion and reversibility scores were calcu-
lated by adding up all individual segment scores for stress and resting
conditions. A reversibility score was then calculated by subtracting
the resting scores from the corresponding stress scores.
Exercise protocol
Patients were instructed to discontinue beta-blockers and calcium
antagonists 48 h before testing and nitrates 6 h before testing. A
symptom-limited treadmill exercise test using the Bruce protocol was
performed. Horizontal or downsloping ST segment depression greater
than 1.0 mm or upsloping more than 1.5 mm 80 ms after the J point
was considered to be positive.
Coronary angiography
Selective coronary angiography was performed in multiple views with
the Judkins technique. Coronary angiograms were analyzed by two
experienced observers who were blinded to the identities and clinical
information of the patients. Vessel scores ranged from zero to three,
according to the number of diseased major epicardial vessels with sig-
nificant stenosis (greater than 50% stenosis of the lumen diameter).
Next, the relationships between HbA1c and the results of exercise
Tl-201 imaging, coronary angiography and mortality were statistically
evaluated. 
Statistical analysis
Data were expressed as proportions or mean ± SD. One-way ANOVA
(with post hoc test) or Kruskal-Wallis test, as appropriate, was used to
compare continuous variables, and the χ2 test was used to compare pro-
portions among groups. Linear regression analysis with Pearson’s coeffi-
cient was used to assess the strength of association between variables.
Multivariate regression analysis was used to identify determinants of
ischemic score. The strength of these relationships was expressed as the
beta coefficient and P value. P<0.05 was considered to be statistically
significant. 
RESULTS
Demographic and clinical data of the subjects are summarized in
Table 1. Except for seven patients who died within 28 days after AMI,
all patients underwent exercise Tl-201 imaging and coronary angiog-
raphy at the end of the fourth week. When examining the results of
exercise test, it was found that all patients reached a mean
7.8±1.5 metabolic equivalents during exercise testing, and the mean
TABLE 1
Demographic and clinical patient data
Level of glycosylated hemoglobin 
<6.5% 6.5%–8.5% >8.5%
(n=25) (n=28) (n=47) P
Age, years (mean ± SD) 56.6±11.5 62.2±8.4 59.6±8.9 NS
Sex, n (male/female) 11/14 19/9 38/9 0.006
Smoking, % 44 46 57 NS
Hypertension, % 52 89 64 0.01
Hyperlipidemia, % 81 54 32 0.001
Obesity (BMI >30 kg/m2), % 19 18 22 NS
Blood glucose, mmol/L 7±1.6 8.3±1.7 9.7±3.2 0.0001
Total cholesterol, mmol/L 5.8±1.1 5.7±2.1 4.9±1.1 0.004
LDL cholesterol, mmol/L 3.6±0.8 3.8±1.65 3.1±0.9 0.01
HDL cholesterol, mmol/L 1.2±0.26 1.1±0.23 0.96±0.2 0.001
Triglycerides, mmol/L 2.23±1.36 2.26±1.55 1.8±0.71 NS
Hemoglobin, mmol/L 8.7±0.75 8.3±1.1 9.1±0.86 NS
Mortality, n 0 0 7 0.009
Exercise testing, n
Positive 8 19 37 0.0001
Scintigraphy 
Total ischemic score 8.5±2.8 10.1±9.4 12.7±6 0.0001
Angiography (number of diseased vessels), n
Single-vessel disease 21 17 4 0.0001
Double-vessel disease 3 5 17 0.0001
Triple-vessel disease or worse 1 6 19 0.001
BMI Body mass index; HDL High-density lipoprotein; LDL Low-density
lipoprotein; NS Nonsignificant
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total ischemic score (TIS) on Tl-201 imaging was 9.6±7.2. Because
seven patients died within the four-week follow-up period, coronary
angiography performed in the remaining 93 patients revealed that
there was single-vessel disease in 42 patients, double-vessel disease in
25 patients and triple-vessel disease or worse in 26 patients. Two
patients died of cardiogenic shock, four died of arrhythmia (ventricu-
lar fibrillation) and one died of acute mitral regurgitation because of
chordal rupture in the follow-up period.
The first major risk factor was male sex. When the relationship
between male sex and clinical results was examined, no significant
relationship was found. However, there were significant relationships
between male sex and TIS (P=0.001), and male sex and the number of
diseased vessels (P=0.001). 
The second major risk factor was obesity. There was no significant
relationship between body mass index and mortality after AMI.
Moreover, there was no significant relationship between body mass
index and TIS, and body mass index and the number of diseased vessels. 
The third major risk factor was smoking. When the relationship
between smoking and mortality after AMI was considered, it was
found that there was no significant relationship. However, there were
significant relationships between smoking and TIS (P=0.002), and
smoking and the number of diseased vessels (P=0.001). 
When considering the other two risk factors, history of hyperten-
sion and hyperlipidemia, there was a significant relationship only
between history of hyperlipidemia and TIS (P=0.0017), and between
history of hypertension and positive exercise test results (P=0.001). 
When the relationship between glucose metabolism at admission
and clinical results was evaluated, it was found that there was a signif-
icant relationship between glucose level at admission and mortality
after AMI (P<0.05). Moreover, there was a significant relationship
between blood glucose level at admission and positive exercise testing
(P<0.001), and TIS obtained four weeks after AMI (P<0.001). 
When considering the HbA1c level as a risk factor, it was found
that there was significant relationship between HbA1c level and mor-
tality after AMI (P=0.006). The mean HbA1c level was greater than
8.5% in all seven patients who died during the four-week follow-up
period. There was also significant correlation between HbA1c levels
at admission and positive exercise test results after the four-week
follow-up period (r=0.327; P=0.001). TIS was significantly different
among the HbA1c groups (Figure 1). In addition, HbA1c levels at
admission and TIS were significantly correlated (Figure 2). There was
also a significant correlation between HbA1c level at admission and
the number of diseased vessels (r=0.69; P=0.0001). Potential determi-
nants of TIS were evaluated in all study subjects by performing
multivariate regression analysis between the values of TIS (dependent
variable) and the values of HbA1c, total cholesterol, high-density
lipoprotein cholesterol and low-density lipoprotein cholesterol (inde-
pendent variables). TIS was positively correlated with HbA1c
(beta=0.39; P=0.0005), but was not significantly correlated with lipid
parameters.
DISCUSSION
Our study demonstrated that in patients with AMI, elevated glucose
and HbA1c levels on admission are associated with higher ischemic
scores and increased mortality rates compared with patients with nor-
mal levels on admission. 
In a recently reported study, Timmer et al (13) reported that higher
admission glucose levels in nondiabetic patients treated with reperfu-
sion therapy for ST segment elevation MI were associated with signif-
icantly larger enzymatic infarct size and lower left ventricular ejection
fraction. This is because a stress response is accompanied by high lev-
els of catecholamines and cortisol, and these hormones increase
glycogenolysis and lipolysis and reduce insulin sensitivity, resulting in
elevated glucose levels (14). Therefore, patients with elevated glucose
levels may represent patients with an increased stress response, for
example, due to more severe hemodynamic compromise or more
extensive myocardial damage (15,16). Stress hyperglycemia increases
mortality, congestive heart failure and cardiogenic shock after AMI
(17). Elevated cytokine, particularly tumour necrosis factor-alpha
(TNF-α), also increases glucose levels. TNF-α is released in AMI and
directly decreases myocardial contractility, probably by inducing
myocardial apoptosis (18-22). TNF-α also causes impaired endothelial
function (20). This, in turn, may be responsible for the impaired
myocardial perfusion. 
The subdiabetic or prediabetic state, also known as impaired glu-
cose tolerance (IGT), is associated with a higher incidence of cardio-
vascular events (23,24), and because many of the studies examining
AMI patients in the hyperglycemic state did not measure HbA1c,
they were not able to demonstrate pre-existing diabetes. Undiagnosed
diabetes was found in 4.3% of patients in one study, contributing to
approximately 10% of mortality (7). Levetan et al (17) also demon-
strated that one-third of hospitalized patients had at least one glucose
level reading higher than 11 mmol/L. In the presence of high glucose
levels, stress hyperglycemia should be differentiated from diabetes.
The admission glucose level can not be used to predict the prognosis
in diabetic patients. Because admission blood glucose levels had begun
to lose its significance in predicting the prognosis of patients with
AMI, clinicians began to focus on HbA1c level. 
HbA1c levels and AMI



























Figure 2) The correlation between glycosylated hemoglobin (HbA1c) lev-
els and total ischemic scores in patients with acute myocardial infarction
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The Diabetes and Insulin-Glucose Infusion in Acute Myocardial
Infarction (DIGAMI) study (3) showed that the glycometabolic
state at hospital admission as defined by blood glucose and HbA1c
was a long-term risk factor in AMI patients with and without dia-
betes. AMI patients without established diabetes had a high preva-
lence of insulin resistance during the hospital phase and the
following three months (2). Hadjadj et al (12) recently reported that
admission plasma glucose, even after adjusting for HbA1c, is a prog-
nostic factor associated with mortality after AMI. Acute, rather than
the chronic, pre-existing glycometabolic states accounted for the
prognosis after AMI. The authors suggested that admission plasma
glucose was an acute reaction rather than the consequence of a pre-
existing metabolic disorder, because adjustment for HbA1c did not
modify the association of admission plasma glucose with mortality
risk. They found a positive correlation between peak creatine kinase
levels and admission plasma glucose concentrations in their
patients. This correlation persisted even when the analysis was
restricted to those patients without previously diagnosed diabetes.
However, they did not find any correlation with HbA1c values in
their study. 
While hyperglycemia is a marker of post AMI stress; insulin resist-
ance is related to the intensity of the stress (12). A chronic pre-
existing abnormal glycometabolic state inevitably affects the degree of
metabolic response to stress; higher blood glucose levels were found
during stress in patients with previously known IGT. Moreover, a
chronic pre-existing abnormal glycometabolic state is inevitably
related to a more diffuse coronary artery tree, and so with increased
TIS. In previous studies (23,24), the relationships between clinical
parameters such as mortality and morbidity were evaluated. However,
in the present study, the relationship of acute and chronic glycometa-
bolic states with the results of exercise, Tl-201 imaging and coronary
angiography was evaluated, and our results support the hypothesis that
both acute and chronic glycometabolic states are an indicator of mor-
tality risk after AMI. There were significant relationships between
admission glucose, HbA1c level and mortality (P=0.006 for HbA1c
level and P=0.043 for glucose level). Patients with HbA1c levels
higher than 6.5% have significantly higher ischemic score than the
patients with HbA1c levels lower than 6.5% (P=0.0001). 
CONCLUSIONS
Our study included only a limited number of patients, and specific car-
diac marker levels, such as creatine phosphokinase myocardial band
and cardiac troponin levels, which can clearly demonstrate the level
of cellular destruction, were not evaluated and compared.
Furthermore, we did not use the gold standard method to diagnose
diabetes or IGT, namely, the oral glucose tolerance test, before dis-
charge. Mortality rates are influenced by factors such as the presence
or absence of recanalization, infarct sites, the time from disease onset
to treatment, Killip classification at admission, ST segment elevation
resolution and left ventricular function. Despite these limitations, our
results clearly demonstrated that both acute and chronic glycometa-
bolic states are an indicator of prognosis after AMI.
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